BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
-
Indonesia doing 'everything' but still struggling to curb fires
-
Three South Korean soldiers injured in DMZ blast: military
-
Once decried as 'human cockfighting', MMA wants Olympic spot
-
New Zealanders pick endangered black robin as Bird of the Year
-
China's Yu, 13, great for swimming says multiple Olympic medallist
-
Asia stocks rise on AI, US-China trade talks optimism
-
Putin's party set to retain power after Russia vote hit by cyberattacks, drones
-
Malaysia's 'elephant whisperer' fights to save Borneo's endangered giants
-
Germany's Merz under pressure after bruising state election losses
-
'I live in fear': 1.5 million Pakistani children sexually exploited online
-
Messi, Miami frustrated in 2-2 draw with San Diego
-
Cowboys beat Commanders, Vikings down Bears as star QBs injured
-
Thousands march in France against 'licence to kill' draft law
-
Crexendo Expands AI Portfolio Through Meetric Partnership, Adding Omnichannel Conversation Intelligence for More Than 250 Platform Licensees
-
Best Gold IRA Accounts 2026 Rankings Released: Top Precious Metals IRA Companies Compared in New Guide
-
4 Hacks for Yearlong Savings on Your Kids' Wardrobes
-
Braves clinch division title as Red Sox reach MLB playoffs
-
Forest fire threatens tourist town in Colombian Andes
-
Bordeaux-Begles hammer Stade Francais despite Jalibert injury
-
Torres on target again as PSG beat 10-man Marseille in Ligue 1
-
Milan and Juventus end blips with home wins
-
Germany's Merz vows to stay course despite new election defeats
-
Bridgeman wins PGA Biltmore title with sizzling 61
-
Carrick demands Man Utd response after 'pathetic' jibes
-
Williams injured as Bears shut down by Vikings
-
Liverpool boss Iraola urges Isak to raise his level
-
US warns of rapid escalation in Middle East war
-
Evenepoel wins record 4th straight world time-trial title
-
Germany's far-right AfD celebrates another state election win
-
France's Macron, Canada's Carney announce closer ties
-
Russia vows revenge for election-day attacks as poll shows ruling party win
-
Carrick defends troubled Man Utd after Fulham escape
-
Spaun late shows snatches PGA Championship win
-
Horror movie 'Resident Evil' tops N. American box office
-
Conceicao strikes as Juventus beat Atalanta
-
Germany's Merz vows to stay course despite new vote losses
-
Britain, Zverev-inspired Germany, Spain complete Davis Cup finals
-
Man City outgun Sunderland despite Brobbey hat-trick, Man Utd rescue Fulham draw
-
Man Utd salvage Fulham draw as pressure mounts on Carrick
-
Mourinho blames ref committee for Real Madrid derby defeat
-
Spanish civil war drama 'The Black Ball' wins at Toronto festival
-
Maresca craves a 1-0 win after eight-goal Man City thriller
-
Germany's Merz shaken by far-right and far-left gains in state votes
-
Atletico Madrid beat Real Madrid in tense derby clash
-
Macron welcomes Canada's Carney to French Atlantic territory
-
Reusser retains world time-trial title
-
Fiorentina frustrate Napoli with Serie A draw, Como upset
-
Man City outgun Sunderland despite Brobbey hat-trick, Liverpool win at Bournemouth
-
Five-star Man City top Premier League after Sunderland thriller
-
Top US, Chinese economic officials meet ahead of Trump-Xi summit
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 4, 2026 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday, March 5th, 2026, at 9:00 am Pacific / 12:00 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending December 31st, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: | 888-506-0062 |
Teleconference International: Participant Access Code: | +1-973-528-0011 346679 |
To watch or listen to a replay of the webcast or teleconference:
Teleconference Replay Expiration: | Thursday, March 19th, 2026 |
Teleconference Replay Domestic: | 877-481-4010 |
Teleconference Replay International: | 919-882-2331 |
Replay Passcode: | 53729 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information:
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc.
View the original press release on ACCESS Newswire
R.Lee--AT
